Quality and Outcome Measurements of Urological Patients

Insel Gruppe AG, University Hospital Bern2,000 enrolled

Overview

Prospectively, all available parameters of urologic patients treated at the study sites will be acquired and stored in multilayered databases. Upon a given samples size, neuronal networks will be trained to define clinical endpoints. Beside uro-oncological patients also patients with other urological diseases will be enrolled.

Study Type

OBSERVATIONAL

Enrollment

2,000

Conditions

Urologic Diseases

Interventions

Standard of careOTHER

Patients are treated according to the standard of care for each individual disease.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All patients treated at the study sites, signed informed consent Exclusion Criteria: * No consent to record medical history

Locations (2)

Roland Seiler

Biel, Switzerland

NOT_YET_RECRUITING

Department of Urology, Hospital Center Biel

Biel, Switzerland

RECRUITING

Outcomes

Primary Outcomes

Disease specific primary endpoint

Neuronal networks will be trained to define the respective endpoints for the diseases

Time frame: 4-5 years

Central Contacts

Roland Seiler, Prof.

CONTACT

+41316321349 Roland.Seiler@insel.ch

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.